Login to Your Account

China's ICT comes out of stealth with CAR T trial results in leukemia

By Shannon Ellis
Staff Writer

Tuesday, May 24, 2016

SHANGHAI – Dozens of Chinese biopharmas have entered the CAR T race, but Shanghai-based Innovative Cellular Therapeutics Co. Ltd. is angling to be the front-runner.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription